Arch Argent Pediatr. 2021 Aug;119(4):S123-S158. doi: 10.5546/aap.2021.S123.
In 1995, the first Guideline on Diagnosis and Treatment for Childhood Asthma was published in Archivos Argentinos de Pediatría. Updates were made in 2007 and 2016. After 5 years, the new contents are presented. The most relevant modifications, although not the only ones, are observed in therapeutic strategies. In this version, treatment is stratified into "levels" (1 to 5). The current paradigm of change in chronic asthma treatment consists in eradicating the prescription of bronchodilators (salbutamol) on demand. Besides that, the option of intermittent treatment with inhaled corticosteroids plus long-acting bronchodilators (LABA) appears for milder forms (levels 1 and 2) in children > 12 years old. There is still not enough evidence to support these options in<12 years old maintaining the previous recommendations in this group. For more details we suggest reading the full document.
1995年,首版《儿童哮喘诊断与治疗指南》在《阿根廷儿科学档案》上发表。2007年和2016年进行了更新。时隔5年,现呈现新内容。最相关的修改(虽非仅有的修改)体现在治疗策略方面。在这个版本中,治疗被分为“级别”(1至5级)。目前慢性哮喘治疗的转变模式在于消除按需使用支气管扩张剂(沙丁胺醇)的处方。除此之外,对于12岁以上儿童的较轻病情(1级和2级),出现了吸入性糖皮质激素加长效支气管扩张剂(LABA)的间歇性治疗方案。对于12岁以下儿童,尚无足够证据支持这些方案,该群体仍维持之前的建议。欲了解更多详情,我们建议阅读完整文档。